Close Menu

Clear Labs Clear Safety Listeria, Environmental Mapping Testing

Jul 22, 2019

Menlo Park, California-based Clear Labs has launched new Listeria testing and environmental mapping capabilities on its Clear Safety next generation sequencing platform.

According to Clear Labs, Clear Safety now catalogs the genetic "fingerprint" of a Listeria sample and compares it to the fingerprints of Listeria previously encountered within a company. The platform can now detect, speciate, and characterize up to seven Listeria species ( monocytogenes, grayi, innocua, ivanovii marthii, seeligeri, and welshimeri) in a single analysis.

Clear Labs also noted that researchers can use the platform's similarity analysis to distinguish resident from transient subtypes of Listeria in the food manufacturing environment, which groups samples containing Listeria with matching fingerprints and tags them with metadata including location, date, and time. The firm's environmental mapping tool then overlays Listeria contamination on a facility map, allowing the team to track the flow of particular subtypes of Listeria through a facility over time. 

More Like This

Dec 10, 2019

Fluidigm Maxpar Antibodies

Fluidigm has released more than 100 pathologist-verified Maxpar antibodies for use with imaging mass cytometry on the Hyperion Imaging System. The company's portfolio now includes antibodies verified for use with both formalin-fixed, paraffin-embedded and frozen tissues. Imaging mass cytometry provides visualization of complex cellular phenotypes and their relationships in the context of cancer, immuno-oncology, and immune-mediated diseases. Using the dual capability of the Hyperion Imaging System, researchers can deeply profile a wide range of samples from blood to tissues using both mass cytometry and imaging mass cytometry, Fluidigm said.

Dec 10, 2019

Bionano Genomics: Prep SP Bone Marrow Aspirate Kit

Bionano Genomics has launched a new kit for DNA isolation from bone marrow aspirates.

The Bionano Prep SP Bone Marrow Aspirate Kit allows for the consistent isolation of ultra high molecular weight DNA in four hours. Bone marrow aspirates, the primary sample type collected from leukemia patients, are traditionally considered a more complex sample type, due to cell clumps and other insoluble impurities.

Dec 10, 2019

GenScript Precision Mutant Library Services

GenScript has launched Precision Mutant Library Services for the drug development, industrial chemical, and synthetic biology markets. The new service utilizes GenScript's proprietary semiconductor oligo synthesis technology to deliver precise control over each synthesized variant. The result is a more diverse and fully covered mutant library with unbiased distribution.

The Precision Mutant Library Services include site-saturation mutagenesis, saturation scanning mutagenesis, or combinatorial mutagenesis libraries. Saturation mutagenesis libraries provide the ability to screen mutations located at several sites within a protein sequence or across the total sequence space. Each position is mutated to all 19 non-wild-type amino acids. Combinatorial mutagenesis libraries involve mutating multiple positions simultaneously across specific target regions of a protein and exploring all possible combinations of mutations.

Dec 10, 2019

Horizon Discovery Predesigned Synthetic sgRNAs

Horizon Discovery is now offering predesigned synthetic single guide RNA (sgRNA). The sgRNAs are available individually or as library collections, and are being offered as an expansion to the company's Edit-R gene engineering platform. Using synthetic sgRNAs enables researchers to achieve reliable gene knockouts, even in complex, difficult-to-edit cell types and experimental models, Horizon said. The synthetic sgRNAs have been designed to maximize the likelihood of functionally knocking out the gene or genes of interest while minimizing off-target effects.

When paired with Cas9 mRNA or Cas9 protein, the sgRNAs also allow researchers to perform DNA-free gene editing in a new one-part format, streamlining their gene editing workflows without the potential for nuclease or guide integration into the cell's genome. They can also be paired with expressed formats such as Cas9 integrated cell lines.

Dec 05, 2019

InterVenn Biosciences OpenPIP Mass Spectrometry Analysis Software

InterVenn Biosciences has made its proprietary mass spectrometry analysis software available for public use. Powered by artificial intelligence and machine learning, OpenPIP reduces the time and cost of integrating and quantifying mass spec data while increasing the quality of output by eliminating observer-based bias. The software is accessed via the Google Cloud Platform and has demonstrated greater than 99 percent concordance with human peak selection, the company said. A publication detailing the specific neural network architecture is currently undergoing peer review. 

Dec 05, 2019

Dante Labs: Whole GenomeH

Dante Labs has launched Whole GenomeH, a next-generation sequencing-based testing service featuring genome assembly with both long and short read technologies.

The test, which costs $1,999, uses both Illumina NovaSeq and Oxford Nanopore Technologies PromethIon sequencing systems.

Dec 04, 2019

Macrogen: Northeast Asia Reference Database

Macrogen of Korea has released the Northeast Asian Reference Database (NARD). It includes whole-genome sequencing and genetic variant data for a panel of 1,779 individuals, including 850 Koreans, 384 Mongolians, 396 Japanese, 91 Chinese, and 58 Hong Kong residents, making it the largest reference panel representing those countries, according to the company. Macrogen expects the database will help improve the accuracy of imputation in genome-wide association studies and predict disease based on polygenic risk scores. Early next year, the company plans to release a second reference panel, from 10,000 individuals.

Dec 04, 2019

Quadrant Biosciences Clarifi ASD

Quadrant Biosciences has launched Clarifi ASD, an epigenetic test designed to aid in the diagnosis of autism spectrum disorder in children 18 months through six year of age. Quadrant said the test is based on regulatory RNAs and microbes in the saliva, and is the result of seven years of research in collaboration with SUNY Upstate Medical University and Penn State College of Medicine. Clarifi is a prescription-only, laboratory-developed test that is intended to be used as an additional tool to standard practices and only for children with a clinical suspicion of ASD, the company said. It is available in all states except New York.

Dec 03, 2019

SiO2 Materials Synergy Tube

SiO2 Materials Science has launched its Synergy Tube, a blood collection tube designed to optimize nucleic acid recovery and cancer tumor cells (CTCs) after blood draw. The firm said that researchers can extract cfDNA/cfRNA and cellular gDNA/RNA from the same tube, allowing users to pair results from the same sample. 

Nov 27, 2019

Devyser HBOC Kit for Hereditary Breast, Ovarian Cancer Testing

Swedish genetic test developer Devyser has launched the HBOC kit for hereditary breast and ovarian cancer testing. The kit is based on Devyser's proprietary next-generation sequencing library prep technology, and provides targeted sequencing of 12 genes in which mutations are associated with an increased risk of developing breast and ovarian cancer. The company said that the workflow takes less than 45 minutes. The HBOC kit is part of Devyser's NGS Oncology suite, complementing the company's BRCA kit that enables simultaneous screening of mutations in the BRCA1 and BRCA2 genes. The new kit is available in the EU and through Devyser distributors in several countries in the Middle East, Southeast Asia, China, South America, and Africa. Customers in countries in which Devyser does not have distributors currently (e.g. the US and Canada) can self-import the assay, a company spokesperson said.

Nov 26, 2019

10x Genomics: Visium Spatial Gene Expression Solution

10x Genomics has launched its Visium Spatial Gene Expression solution. The assay provides researchers the ability to map where gene activity is occurring in a tissue specimen, with whole-transcriptome analysis of up to hundreds of thousands of cells on a tissue section.

Visium builds on earlier products from Spatial Transcriptomics, which 10x acquired in 2018, offering five times more spots within a capture area while reducing the time it takes from three days to one day.

Visium also includes turn-key software and requires access to an optical microscope.

Nov 22, 2019

Biocept TRK Assay

Biocept said it has launched a new assay for detection of TRK proteins in circulating tumor cells, intended to help inform physicians of patients' NTRK fusion status, an actionable biomarker that can be used to qualify patients for treatment with TRK inhibitor therapies.

The launch brings the company's CLIA lab test menu to 20 assays, including a variety of other single-gene tests analyzed in either circulating cell-free DNA or CTCs, and a next-gen sequencing panel test for lung cancer biomarkers.

Nov 20, 2019

Thermo Fisher Scientific Applied Biosystems SeqStudio Genetic Analyzer for Human Identification

Thermo Fisher Scientific has launched the Applied Biosystems SeqStudio Genetic Analyzer for Human Identification, a capillary electrophoresis platform. The system is designed for small- to medium-sized forensic DNA and paternity laboratories. It has been validated according to Scientific Working Group on DNA Analysis Methods (SWGDAM) guidelines on several Applied Biosystems STR amplification kits. The instrument uses an integrated cartridge that combines a capillary array, polymer reservoir, and anode buffer.

Nov 19, 2019

HTG Molecular Diagnostics EdgeSeq Reveal V 2.0

HTG Molecular Diagnostics has released its HTG EdgeSeq Reveal data analysis software, version 2.0. The Tucson, Arizona-based firm said that the new software contains enhanced functionality, allowing rapid data analysis from the HTG EdgeSeq Autoimmune Panel.

Nov 15, 2019

MedGenome South Asian Research Genotyping Array (SARGAM)

MedGenome has introduced the South Asian Research Genotyping Array, which leverages MedGenome's proprietary database of 2.5 million variants unique to the South Asian population and not available in any publicly available genetic database. MedGenome will use sequence data generated in its facility in Bengaluru, India to continue to identify unique content for SARGAM, which is based on Thermo Fisher Scientific's Applied Biosystems Axiom genotyping arrays. MedGenome said that SARGAM is intended to enable discovery research involving South Asian population cohorts, and will be ideal for consumer genomics solutions like ancestry and pharmacogenomics for the South Asian population.

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.

Dec
17
Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.